RCMI Coordinating Center (RCMI CC) Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Boukli, Nawal M.
PropertyValue
overview Dr. Boukli is a Professor in the department of microbiology and immunology and is the Director of the Biomedical Proteomics Facility at the Universidad Central del Caribe, School of Medicine, PR, USA. Dr. Boukli got her Doctoral degree in Molecular Biology from the University of Geneva, Switzerland, where she worked in early molecular signaling events such as the type three secretion pathway in Rhyzobium bacteria. Dr. Boukli did her postdoctoral fellowship at the University of Missouri where she gained more expertise in proteomics technology. She then joined the Universidad Central Del Caribe where she organized a high-throughput Proteomic Core Facility. Dr. Boukli’s research uses the latest technologies, including quantitative proteomics multiplexing with isobaric tags approaches and molecular and flow cytometric analyses for the detection of biomarkers and molecular signatures in HIV, drug and alcohol of abuse, cancer and multiple sclerosis. Dr. Boukli has numerous peer-review articles and NIH funded grants on these and related topics. Dr. Boukli is also interested in how endoplasmic reticulum stress responses and cell fate decision can regulate the network of apoptotic and survival signal events in different cells and systems and the anti-cancer and anti-HIV mechanistic effects of natural compounds for cancer and HIV treatment as some of her publications demonstrate (Boukli et al, 2010, Boukli et al, 2011, Boukli et al, 2012, Rivera et al, and Boukli, 2016, Lopez et al, and Boukli, 2017, Rodriguez et al, and Boukli, 2018), see publications below). In addition to her research pursuits, Dr. Boukli has been active in training young investigators, both individually (as a mentor and proteomics facility resource, post-doctoral fellows, medical students, Master and PhD trainees) and in the classroom (where she has developed a proteomics graduate-level course and several workshops on proteomics in clinical research).  Language Skills: • French (native) • Arabic (native) • English (Fluent, speaking, Fluent reading, Fluent writing) • Spanish (Fluent, speaking, Fluent reading, Fluent writing) • Italian (Fluent, speaking, Fluent reading, intermediate writing)
preferred title Director of Biomedical Proteomics Facility
Search Criteria
  • Proteomics
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support